Recent Updates
Recently added Catalysts
EBS Neutral Sentiment Score: 60/100

Emergent BioSolutions to Release Second Quarter 2023 Financial Results and Conduct Conference Call on August 8, 2023

Tuesday, July 25, 2023 1 min read
Key Takeaway: Emergent BioSolutions Inc. will host a conference call on August 8, 2023, to discuss its financial results for the second quarter of 2023. The call will also touch on recent business developments and provide revenue guidance for the third quarter and full year. Participants can join via webcast or telephone after registering in advance. A replay of the call will be available on the company’s investors page.

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions will provide a financial update for Q2 2023.
  • The conference call will cover revenue guidance for Q3 2023.
  • Investors are invited to participate and access a replay of the call.

Full Press Release Details

GAITHERSBURG, Md., July 25, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 8, 2023, at 5:00 pm eastern time to discuss the financial results for the second quarter of 2023, recent business developments, revenue guidance for the third quarter of 2023, and financial outlook for full year 2023.
Conference Call Information
Participants can access the conference call live via webcast from the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
Vice President, Investor Relations
Senior Director, Media Relations
mediarelations@ebsi.com

Tags

earnings announcement

Frequently Asked Questions

When is Emergent BioSolutions' conference call?

The conference call is scheduled for August 8, 2023, at 5:00 pm ET.

How can I access the conference call?

You can access it live via webcast on Emergent's Investors page or by phone after registering.

What will be discussed in the conference call?

The discussion will cover second quarter 2023 results, business updates, and revenue guidance.

Where can I find the replay of the call?

The replay will be available on the Investors page of Emergent's website.

Who should I contact for media inquiries?

You can contact media relations at mediarelations@ebsi.com.

Tags: EBS Viatris Investor Conferences Healthcare Emergent BioSolutions financial results Q2 2023 conference call
Last updated: Jul 25, 2023